These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 24098563)
1. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice. Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563 [TBL] [Abstract][Full Text] [Related]
3. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis. Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501 [TBL] [Abstract][Full Text] [Related]
4. Use of the common marmoset to study Burkholderia mallei infection. Jelesijevic T; Zimmerman SM; Harvey SB; Mead DG; Shaffer TL; Estes DM; Michel F; Quinn FD; Hogan RJ; Lafontaine ER PLoS One; 2015; 10(4):e0124181. PubMed ID: 25860021 [TBL] [Abstract][Full Text] [Related]
5. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders. Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026 [TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962 [TBL] [Abstract][Full Text] [Related]
7. Development of Burkholderia mallei and pseudomallei vaccines. Silva EB; Dow SW Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691 [TBL] [Abstract][Full Text] [Related]
12. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? Titball RW; Burtnick MN; Bancroft GJ; Brett P Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210 [TBL] [Abstract][Full Text] [Related]
13. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938 [TBL] [Abstract][Full Text] [Related]
14. Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches. Aschenbroich SA; Lafontaine ER; Hogan RJ Expert Rev Vaccines; 2016 Sep; 15(9):1163-81. PubMed ID: 27010618 [TBL] [Abstract][Full Text] [Related]
15. Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice. Bearss JJ; Hunter M; Dankmeyer JL; Fritts KA; Klimko CP; Weaver CH; Shoe JL; Quirk AV; Toothman RG; Webster WM; Fetterer DP; Bozue JA; Worsham PL; Welkos SL; Amemiya K; Cote CK PLoS One; 2017; 12(2):e0172627. PubMed ID: 28235018 [TBL] [Abstract][Full Text] [Related]
16. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Galyov EE; Brett PJ; DeShazer D Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691 [TBL] [Abstract][Full Text] [Related]
17. Protection from pneumonic infection with burkholderia species by inhalational immunotherapy. Goodyear A; Kellihan L; Bielefeldt-Ohmann H; Troyer R; Propst K; Dow S Infect Immun; 2009 Apr; 77(4):1579-88. PubMed ID: 19179415 [TBL] [Abstract][Full Text] [Related]
18. Burkholderia vaccines: are we moving forward? Choh LC; Ong GH; Vellasamy KM; Kalaiselvam K; Kang WT; Al-Maleki AR; Mariappan V; Vadivelu J Front Cell Infect Microbiol; 2013; 3():5. PubMed ID: 23386999 [TBL] [Abstract][Full Text] [Related]
19. Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice. Bernhards RC; Cote CK; Amemiya K; Waag DM; Klimko CP; Worsham PL; Welkos SL Arch Microbiol; 2017 Mar; 199(2):277-301. PubMed ID: 27738703 [TBL] [Abstract][Full Text] [Related]
20. An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency. Saikh KU; Dankmeyer JL; Zeng X; Ulrich RG; Amemiya K Immun Inflamm Dis; 2019 Mar; 7(1):7-21. PubMed ID: 30569531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]